BENJAMIN GOLDSTEIN: Open Payments
NPI 1578978383 · PIKESVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$243 in 5 payments from 5 companies in 2025. Trend: 2023 $512 · 2024 $277 · 2025 $243
Food & beverage: $243
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 1 | $125 |
| AstraZeneca Pharmaceuticals LP | 1 | $33 |
| Janssen Biotech, Inc. | 1 | $30 |
| ABBVIE INC. | 1 | $28 |
| Exelixis Inc. | 1 | $27 |
Products named: AREXVY, RYBREVANT, EPKINLY, CABOMETYX.
Industry payments across MD — which companies pay providers there.
